mail
versión imprimible
 
 

4th iPSC Drug Development and Manufacturing Summit

Evvnt Promotion / evvnt
-
01.10.2024 - 03.10.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temas de la conferencia
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2453698-3?pid=4832

Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, and more
 

Información e inscripción:

https://go.evvnt.com/2453698-2?pid=4832
Mr. Elliot Karmel
 
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für WienHilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnologie und MedizinCharité International AcademyÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzAMREF - African Medical and Research Foundation